Trial Profile
Understanding the Prognostic Benefits of Exercise and Anti-Depressant Therapy (UPBEAT).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Depressive disorders
- Focus Biomarker; Therapeutic Use
- Acronyms UPBEAT
- 01 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2011 Planned number of patients changed from 200 to 150 as reported by ClinicalTrials.gov.
- 08 Nov 2011 Planned End Date changed from 1 Feb 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.